Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19).
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
09 Nov 2020
09 Nov 2020
Historique:
received:
22
10
2020
accepted:
02
11
2020
entrez:
6
5
2022
pubmed:
10
11
2020
medline:
10
11
2020
Statut:
epublish
Résumé
The recent release of the main protein structures belonging to SARS CoV-2, responsible for the coronavirus disease-19 (COVID-19), strongly pushed for identifying valuable drug treatments. With this aim, we show a repurposing study on FDA-approved drugs applying a new computational protocol and introducing a novel parameter called IVS
Identifiants
pubmed: 35519188
doi: 10.1039/d0ra09010g
pii: d0ra09010g
pmc: PMC9057693
doi:
Types de publication
Journal Article
Langues
eng
Pagination
40867-40875Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
RSC Adv. 2020 Aug 28;10(53):32148-32155
pubmed: 35518160
PLoS One. 2020 Sep 11;15(9):e0238907
pubmed: 32915876
Front Microbiol. 2020 Jul 23;11:1796
pubmed: 32793181
Mar Drugs. 2020 Apr 23;18(4):
pubmed: 32340389
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Pharm Biomed Anal. 2018 Jan 5;147:378-399
pubmed: 29031512
J Pharm Biomed Anal. 2018 Jan 5;147:400-416
pubmed: 28755849
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
J Nat Prod. 2011 Jun 24;74(6):1401-7
pubmed: 21542600
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Chem Inf Model. 2009 Feb;49(2):377-89
pubmed: 19434839
J Proteome Res. 2020 Nov 6;19(11):4678-4689
pubmed: 32786685
Expert Rev Clin Pharmacol. 2016;9(5):655-63
pubmed: 26943823
Am J Cardiovasc Drugs. 2017 Aug;17(4):299-309
pubmed: 28255870
J Transl Med. 2020 Jun 25;18(1):257
pubmed: 32586380
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
J Transl Med. 2020 Apr 14;18(1):165
pubmed: 32290847
Nucleic Acids Res. 2019 Jan 8;47(D1):D464-D474
pubmed: 30357411
Drugs. 2016 Oct;76(16):1567-1578
pubmed: 27730529
RSC Adv. 2020 Apr 21;10(27):15775-15783
pubmed: 35493667
Chem Biol Drug Des. 2007 Feb;69(2):146-8
pubmed: 17381729
F1000Res. 2020 Feb 21;9:129
pubmed: 32194944
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
Eur J Pharm Sci. 2020 Dec 1;155:105522
pubmed: 32827661
J Mol Biol. 2011 Nov 25;414(2):272-88
pubmed: 22004941
Bioorg Med Chem. 2012 Jun 1;20(11):3596-602
pubmed: 22537682
Future Med Chem. 2020 Oct;12(20):1815-1828
pubmed: 32787684
J Chem Inf Model. 2020 Jan 27;60(1):421-433
pubmed: 31873008
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
ChemMedChem. 2020 Jun 4;15(11):907-932
pubmed: 32324951
Expert Opin Drug Discov. 2019 Aug;14(8):755-768
pubmed: 31146609
Molecules. 2020 Jul 13;25(14):
pubmed: 32668701
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Chem Inf Model. 2020 Dec 28;60(12):5771-5780
pubmed: 32530282
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
J Chem Inf Model. 2019 Nov 25;59(11):4678-4690
pubmed: 31593460
J Infect. 2020 May;80(5):554-562
pubmed: 32169481
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Int J Mol Sci. 2020 May 30;21(11):
pubmed: 32486229
Int J Biol Macromol. 2020 Dec 1;164:1693-1703
pubmed: 32745548
Tetrahedron Lett. 2020 Oct 1;61(40):152336
pubmed: 32868957
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
ACS Omega. 2019 Dec 03;4(25):21370-21380
pubmed: 31867532
ACS Omega. 2019 Sep 17;4(14):16233-16241
pubmed: 31592173
J Biomol Struct Dyn. 2022 Jan;40(1):101-116
pubmed: 32815796
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Drugs. 2009;69(5):609-32
pubmed: 19368420
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508